Literature DB >> 24865321

Risk factors associated with high prevalence rates of hepatitis C infection in Egypt.

Celeste Reker1, K M Islam2.   

Abstract

INTRODUCTION: Egypt has the highest reported prevalence of hepatitis C virus (HCV) globally. Until now, no systematic review has been conducted to understand risk factors associated with these high prevalence rates of HCV. This study attempted to identify the various HCV risk factors in Egypt responsible for the high incidence and prevalence rates.
METHODS: Using systematic literature review methods, we searched databases for eligible manuscripts, selecting cohort and case-control studies published in English. Peer-reviewed papers published between 2008 and February 2013 were included. A total of 11 articles met the study selection criteria.
RESULTS: The most examined risk factors found during our review analysis were surgery, transfusion, and age (64-82% of total articles; n = 11). Multiple risk factors held significant association with HCV infection in the included research.
CONCLUSIONS: Based on this review, the main HCV risk factor categories are unsafe medical practices and familial risk factors. Improving medical safety and encouraging familial education on HCV may help reduce the incidence of the disease. Most risk factors for HCV transmission in Egypt are healthcare-associated. Primary prevention of HCV infection remains important to reduce HCV transmission. Further research should also focus on risk factor dynamics of HCV in Egypt to reduce transmission and HCV disease burden.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Egypt; Hepatitis C; Risk factor

Mesh:

Year:  2014        PMID: 24865321     DOI: 10.1016/j.ijid.2014.02.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  14 in total

Review 1.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

2.  Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.

Authors:  Mazen Naga; Mona Amin; Dina Algendy; Ahmed Elbadry; May Fawzi; Ayman Foda; Serag Esmat; Dina Sabry; Laila Rashed; Samia Gabal; Manal Kamal
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

3.  Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.

Authors:  Adam Trickey; Margaret T May; Charlotte Davies; Huma Qureshi; Saeed Hamid; Hassan Mahmood; Quaid Saeed; Matthew Hickman; Nancy Glass; Francisco Averhoff; Peter Vickerman
Journal:  Am J Trop Med Hyg       Date:  2017-10-12       Impact factor: 2.345

Review 4.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

5.  Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis.

Authors:  Zhao Hui Yang; Su Xian Yang; Cheng Zhi Qin; Yun Xiu Chen
Journal:  Hepat Mon       Date:  2015-05-23       Impact factor: 0.660

6.  TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.

Authors:  Ming-Li Chou; Thierry Burnouf; Shun-Pang Chang; Ting-Chun Hung; Chun-Ching Lin; Christopher D Richardson; Liang-Tzung Lin
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 7.  Identifying Opportunity for Online Education to Address HIV/HCV Knowledge Gaps in Health Professionals and Students in Egypt.

Authors:  Aya Khalil; Mahmoud Shaltout; Sergio Costa
Journal:  Ann Glob Health       Date:  2018-11-05       Impact factor: 2.462

8.  Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China.

Authors:  Hongqin Xu; Ge Yu; Haibo Sun; Juan Lv; Moli Wang; Fei Kong; Mingyuan Zhang; Xiumei Chi; Xiaomei Wang; Ruihong Wu; Xiuzhu Gao; Jin Zhong; Bing Sun; Jing Jiang; Yu Pan; Junqi Niu
Journal:  BMC Public Health       Date:  2015-09-19       Impact factor: 3.295

9.  Occult Hepatitis C Virus Infection in Hemodialysis Patients; Single Center Study.

Authors:  Samya El-Shishtawy; Nevine Sherif; Emad Abdallh; Laila Kamel; Mohamed Shemis; Abdel Aziz Ali Saleem; Haitham Abdalla; Hesham Gamal El Din
Journal:  Electron Physician       Date:  2015-12-20

10.  Systematic overview of hepatitis C infection in the Middle East and North Africa.

Authors:  Karima Chaabna; Sohaila Cheema; Amit Abraham; Hekmat Alrouh; Albert B Lowenfels; Patrick Maisonneuve; Ravinder Mamtani
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.